In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this...

The paper examines whether, among inpatient psychiatric admissions in California, for-profit (FP) hospitals engage in cream skimming, i.e., choosing patients for some characteristic(s) other than their need for care, which enhances the profitability of the provider. We propose a novel approach...

This research analyzes the performance of the health insurance CO-OPs, examines their medical services and operating efficiency, and discusses an efficiency-based goal-oriented approach for potential cost reductions, premium changes, and government subsidies. Most CO-OPs suffer underwriting...

Nach der Einführung der Pflegeversicherung Mitte der neunziger Jahre haben sich die Pflegearrangements in Westdeutschland signifikant zu Lasten der informellen Pflege durch Angehörige verändert, wie erstmals anhand einer deskriptiven SOEP-Analyse gezeigt wird. Dies steht im Einklang mit den...

A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...

Competition among health insurers is widely considered to be a means of enhancing efficiency and containing costs in the health care system. In this paper, it is argued that this could be unsuccessful since health care providers hold a strong position on the market for health care services....

Dieser Aufsatz bietet einen einführenden Überblick zur globalen Gesundheitsökonomie – unter besonderer Berücksichtigung der Allokation von Ressourcen, der Messung medizinischer Ergebnisse und der Bestimmungsgründe internationaler Variation. Daran anschließend werden gesundheitspolitische...

We consider a two-period model. In the first period, individuals consume two goods: one is sinful and the other is not. The sin good brings pleasure but has a detrimental effect on second period health and individuals tend to underestimate this effect. In the second period, individuals can...

TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...